Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
Launched by EYE CLINIC MEDIC ZULJAN JUKIC · Sep 26, 2012
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • presence of nonproliferative diabetic retinopathy
- • presence of the cataract (LOCS 2-3)
- Exclusion Criteria:
- • other chronic or acute eye diseases
- • hypersensitivity to any component of the diclofenac eye-drops patients on oral anticoagulant therapy
- • allergy to salycilates
About Eye Clinic Medic Zuljan Jukic
Eye Clinic Medic Zuljan Jukic is a leading ophthalmic research institution dedicated to advancing eye care through innovative clinical trials and cutting-edge treatments. With a focus on enhancing patient outcomes and understanding ocular diseases, the clinic employs a multidisciplinary approach, combining expertise in clinical ophthalmology with rigorous scientific methodology. Our commitment to ethical practices and patient safety ensures that all trials are conducted in compliance with the highest regulatory standards. By collaborating with top researchers and healthcare professionals, Eye Clinic Medic Zuljan Jukic aims to contribute significantly to the field of ophthalmology and improve the lives of individuals affected by vision impairments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Split, , Croatia
Patients applied
Trial Officials
Ljubo Znaor, MD PhD
Principal Investigator
Clinical Hospital Center, Split
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials